| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | 0.1 | 0.1 |
| Net income | -0.8 | -0.6 |
| EPS (diluted, $ a share) | $-0.12 | $-0.14 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -25.5% |
|---|
10-Q filed with the SEC, NASDAQ: AMST. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Amesite Inc.: key numbers
- Share price
- $0.5468Close, Nov 16
- Market cap
- $3.58M
- Shares outstanding
- 6.55MLatest SEC cover page
- Sector
- Technology
- Industry
- Services-Prepackaged SoftwareSIC 7372
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Amesite Inc.
All →Amesite Announces Contract Win
Amesite Inc. entered into a new NurseMagic enterprise agreement with a healthcare organization serving approximately 2,000 patients. The contract involves deploying Amesite's AI-native documentation platform to automate EMR assessments and care plans. While the specific counterparty name and deal value were not disclosed, the company framed the win as a material expansion of its recurring revenue and enterprise user base.
Amesite Nasdaq/NYSE Compliance Notice
Amesite Inc. received a deficiency notice from Nasdaq on November 11, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Management is monitoring the situation and may consider a reverse stock split if necessary to maintain its listing on The Nasdaq Capital Market.
- Counterparty
- Nasdaq
- Term
- 180 days
Amesite Shareholder Meeting
Amesite Inc. has scheduled its next Annual Meeting of Stockholders for December 10, 2026. The company established September 27, 2026, as the deadline for stockholders to submit proposals or director nominations for inclusion in the proxy materials.
Amesite Investor Presentation
Amesite Inc. has prepared presentation materials for use at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026. The presentation highlights the company's AI-powered enterprise solutions for the $1.5 trillion post-acute care market, including its NurseMagic B2B platform and EMR functionality. The company reported international reach across 21 countries and high user ratings for its clinical documentation applications.
- Counterparty
- H.C. Wainwright 28th Annual Global Investment Conference